Intelligent Bio-Systems, Inc., a Qiagen Company, founded in 2005, is a leading developer and manufacturer in the biotechnology and healthcare industries. Specializing in next-generation DNA sequencing systems, including instruments, reagents, and disposables, the company is the exclusive licensee of seminal patents from Columbia University. Having merged with a division of Qiagen in 2012, Intelligent Bio-Systems secured a significant $750.00K in debt financing investment on 28 December 2011 from the Massachusetts Life Sciences Center.
No recent news or press coverage available for Intelligent BIo-Systems, Inc.- A Qiagen Company.